Press release
Global Graft Versus Host Disease Treatment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024
Versus Host Disease Treatment Market
Global graft versus host disease treatment market was valued at US $ XX Mn and expected to grow at 5.5% Compound Annual Growth Rate (CAGR) from 2018 to 2024
Market Outline: Graft Versus Host Disease Treatment Market
Graft versus host disease is an immune-mediated disease. It is the medical complication in which there would be a complex interaction between the donor and the adaptive immunity of the recipient. The disease occurs when the bone marrow or the stem cells are transplanted. The treatment using the stem cells and bone marrow are used in the reconstruction of the damaged cells which surround the cancer cells. It is also used in the during solid organ transplantation. The chances of developing graft versus host disease is more in the allogeneic transplantation.
Market Dynamics: Graft Versus Host Disease Treatment Market
Rising count of the allogeneic hematopoietic stem cell transplant and increase in the prevalence of cancer patients are majorly driving the growth of graft versus host disease treatment market. The increasing bone marrow transplantations for various types of cancers is likely to drive the growth of the market. The growing R&D activities is helping in fastening up the drug development process which is expected to add fuel for the growth of the market. However, the higher investment in the initial stages of the clinical trials is likely to hamper the growth of the market. The strict government regulations for approvals is also hindering the growth of the graft versus host disease treatment market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Graft Versus Host Disease Treatment Market
Graft versus host disease treatment market is segmented based on the product type, disease type, and distribution channel
Based on the product type, the market is segmented into the following:
• Monoclonal Antibodies
• Tyrosine Kinase Inhibitors
• Thalidomide
• mTOR Inhibitors
• Others
Based on the disease type, the market is segmented into the following:
• Acute Graft vs. Host Disease (aGvHD)
• Chronic Graft vs. Host disease (cGvHD)
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Graft Versus Host Disease Treatment Market
Geographically, global graft versus host disease treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America graft versus host disease treatment market growing due to increase in the prevalence of cancer. The rising count of the bone transplantations is also considerably high in this region. The increasing healthcare expenditure and adoption of the modern treatment options are adding scope for the growth of the market in this region.
Competition Assessment: Graft Versus Host Disease Treatment Market
Some of the players in the global graft versus host disease treatment market include:
• Novartis AG (Switzerland)
• Merck & Co. (U.S)
• Soligenix, Inc. (U.S)
• Mesoblast Ltd (Australia)
• Sanofi (France)
• Neovii Biotech GmbH (Switzerland)
• Astellas Pharma Inc. (Japan)
• Mallinckrodt Pharmaceuticals (UK)
Ask Analyst about this report @
https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/#ulp-14mlyhjMGhVjZqa3
Notable Market Developments: Graft Versus Host Disease Treatment Market
In November 2017, Merck & Co., Inc. received FDA Approval of PREVYMIS (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/graft-versus-host-disease-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Graft Versus Host Disease Treatment Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 here
News-ID: 1077862 • Views: …
More Releases from Precision Business Insights
Gaming Controller Market Rising Demand for Gaming Stations and eSports
According to the Precision Business Insights (PBI), latest report the gaming controller market size was valued at USD 2,382.1 million in 2023, growing at an 8.5% CAGR from 2024 to 2030. The key drivers of the expansion of the global gaming controller include the enhanced gaming experience, technology advancements, consumer preferences and ergonomics, competitive gaming and esports, intuitiveness, and portability of the gaming controllers.
View Full Report: https://www.precisionbusinessinsights.com/market-reports/gaming-controller-market …
Next Generation Dietary Supplements Market Size, Growth Opportunities 2024-2030
According to Precision Business Insights (PBI), the latest report, the global next-generation dietary supplements market was valued at USD 10,752.3 million in 2023 and is expected to grow at a CAGR of 8.8% from 2024-2030. The primary factors that drive the market are the growing demand for rising consumer knowledge of the various health benefits of Next Generation Dietary Supplements, as well as rising disposable income levels, fuel market expansion…
Catamaran Market Increasing Popularity Of Water Sports And Fishing Activities
According to Precision Business Insights (PBI), the latest report, the catamaran market is valued at USD 1,635.7 million in 2023 and is anticipated to grow a CAGR of 4.9% over the forecast period. The primary factors that drive the market are the growing demand for Catamaran pushes the market to enhance efficiency, minimize time consumption, and reduce post-harvest operating losses. Catamaran are good solutions for reducing high labour costs since…
Refrigerated Display Cases Market Size, Share, Growth Trends and Forecast 2024-2 …
According to Precision Business Insights (PBI), latest report, the refrigerated display cases market was valued at USD 8,248.5 million in 2023 and is expected to grow at a 5.1% CAGR from 2024 to 2030. The primary drivers of the expansion of the global refrigerated display cases market include the increasing demand for frozen food and drinks among urban consumers. In addition, growing awareness about environment sustainability and energy efficiency is…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
